Twin Peaks Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,363
Closed -$151K 1625
2026
Q1
$151K Buy
+5,363
New +$143K 0.04% 226
2025
Q3
Sell
-5,424
Closed -$134K 1541
2025
Q2
$134K Buy
+5,424
New +$126K 0.04% 201
2024
Q1
Sell
-7,359
Closed -$212K 131
2023
Q4
$212K Buy
+7,359
New +$222K 0.14% 114

Other funds holding PFE

Twin Peaks Wealth Advisors's PFE Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Pfizer (PFE) in Q2 2026, closing a stake of 5,363 shares — an estimated $151K sold.

Twin Peaks Wealth Advisors first reported a position in PFE in Q4 2023 and held it in 3 quarters. The position peaked at $212K in Q4 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 5,363 Pfizer shares in Q2 2026, an estimated $151K.
  • Twin Peaks Wealth Advisors first reported a position in Pfizer in Q4 2023 and held it in 3 quarters.
  • Twin Peaks Wealth Advisors's Pfizer position peaked at $212K in Q4 2023.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.